ERIS - BreakoutThe price has been consolidating since August 2024, forming a triangle pattern. It has now broken out of the triangle, presenting an entry opportunity with a stop-loss placed below the large green candle.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
25.60 INR
3.92 B INR
20.09 B INR
33.65 M
About ERIS LIFESCIENCES LTD
Sector
CEO
Amit Indubhushan Bakshi
Headquarters
Ahmedabad
Website
Founded
2007
ISIN
INE406M01024
FIGI
BBG00GX73BH6
Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its brands include Eritel, Glimsave, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.
ERIS Lifesciences for 25% gainsDate: 3 Dec’24
Symbol: ERIS
Timeframe: Weekly
ERIS Lifesciences currently seems to be in Wave V of 3 which is heading towards 1960-70 (25% from current price of 1470) as seen in the chart. Wave 4 could then correct back to 1300 levels.
The company, in the recently announced September quarter resul
ERIS Lifescience Promising Pattern.
Good pattern, good volume and a good candle.
Entry from cmp - up to 1450 range.
Risk 12% from CMP.
Reward 25%
RR: 1:2
This is just my view. Please do not treat this as a Buy/Sell Recommendation.
ERIS Breaking RangeSL Day candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. risk ratio 1:1 to manage modified SL. This is not call, Just my idea. Please understand your risk and take full responsibility of your actions
ERIS :: Buy for 1500 targetSymmetrical Triangle break!!
Accumulation range :: 1340-1350
Stopless :: below 1300 on closing bases.
Target :: 1490-1500 (1:2 Risk:Reward)
elliotwaves study ERIS LIFESCIENCESof the 5 waves corrective wave 3-4 and impulse 4-5 is pending. the final cycle in this stock can be expected to be complete by Jan2029 as it is cyclical in nature. We can confirm as long as wave 4 doesn't cross wave1.
The company is a leading player in the domestic branded formulations market. It i
Eris Life Sciences - Long for target of 878 , 1000 , 1197On Monthly chart Eris Life has created Cup and Handle pattern
Possible targets
T1 - 878
T2- 1000
T3 - 1087
T4 - 1197
SL - 600 on monthly closing basis
Multiyear Breakout possibleTesting the same level a third time after 2018 and 2021. Wait for Breakout
Rising Wedge Breakout in ErisEris having rising wedge pattern breakout. Stock could see upside till 1225 in coming days
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ERIS is 1,471.20 INR — it has increased by 0.65% in the past 24 hours. Watch ERIS LIFESCIENCES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange ERIS LIFESCIENCES LTD stocks are traded under the ticker ERIS.
ERIS stock has fallen by −1.70% compared to the previous week, the month change is a 10.87% rise, over the last year ERIS LIFESCIENCES LTD has showed a 57.02% increase.
We've gathered analysts' opinions on ERIS LIFESCIENCES LTD future price: according to them, ERIS price has a max estimate of 1,680.00 INR and a min estimate of 1,230.00 INR. Watch ERIS chart and read a more detailed ERIS LIFESCIENCES LTD stock forecast: see what analysts think of ERIS LIFESCIENCES LTD and suggest that you do with its stocks.
ERIS reached its all-time high on Sep 6, 2024 with the price of 1,522.05 INR, and its all-time low was 321.00 INR and was reached on Mar 13, 2020. View more price dynamics on ERIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ERIS stock is 2.17% volatile and has beta coefficient of −0.21. Track ERIS LIFESCIENCES LTD stock price on the chart and check out the list of the most volatile stocks — is ERIS LIFESCIENCES LTD there?
Today ERIS LIFESCIENCES LTD has the market capitalization of 198.81 B, it has increased by 0.72% over the last week.
Yes, you can track ERIS LIFESCIENCES LTD financials in yearly and quarterly reports right on TradingView.
ERIS LIFESCIENCES LTD is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ERIS LIFESCIENCES LTD revenue for the last quarter amounts to 7.41 B INR, despite the estimated figure of 7.41 B INR. In the next quarter, revenue is expected to reach 7.73 B INR.
ERIS net income for the last quarter is 915.90 M INR, while the quarter before that showed 831.80 M INR of net income which accounts for 10.11% change. Track more ERIS LIFESCIENCES LTD financial stats to get the full picture.
ERIS LIFESCIENCES LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 1.28% and 26.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 3, 2024, the company has 3.08 K employees. See our rating of the largest employees — is ERIS LIFESCIENCES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ERIS LIFESCIENCES LTD EBITDA is 8.38 B INR, and current EBITDA margin is 34.88%. See more stats in ERIS LIFESCIENCES LTD financial statements.
Like other stocks, ERIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ERIS LIFESCIENCES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ERIS LIFESCIENCES LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ERIS LIFESCIENCES LTD stock shows the buy signal. See more of ERIS LIFESCIENCES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.